Good Start Genetics has expanded its menu of next-generation sequencing-based testing services for carrier screening (see story, same issue). The company now screens for 23 diseases recommended in guidelines by major medical societies.
Recent additions to its menu include: dihydrolipoamide dehydrogenase deficiency, familial hyperinsulinism, glycogen storage disease type 1a, Joubert syndrome 2, maple syrup urine diseases type A/B, nemaline myopathy, Usher syndrome type 1F, Usher syndrome type III, and Walker-Warburg syndrome.